Funders › NY › Emerald Foundation Inc Co Solomon Blum Heymann › 2018
Grants paid by Emerald Foundation Inc Co Solomon Blum Heymann, tax year 2018
EIN 13-3912580 · New York, NY · Form 990-PF, Part XV · NTEE T20J
In tax year 2018, Emerald Foundation Inc Co Solomon Blum Heymann (EIN 13-3912580) reported 11 grants paid totaling $1,350,000. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2018
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2018 | Salk Institute for Biological Studies La Jolla, CA | B | $150,000 | paid | To analyze the potential therapeutic effect of blocking fatty acid synthesis in non-small cell lung cancer through the use of novel enzymatic inhibitors. | 201901229349101720 |
| 2018 | Georgetown University Washington, DC | B | $150,000 | paid | To investigate how USP-13, a protein involved in the clearance of misfolded and abnormal proteins, may function as a regulator to clear proteins implicated in the development and progression of neurodegenerative diseases. | 201901229349101720 |
| 2018 | Regents of the University of California La Jolla, CA | U | $150,000 | paid | To (1) define a microbiome growth curce in healthy children, (2) determine when and why deviation from this curve occurs, and (3) investigate known, as well as discover new, microbiome-linked disorders and relationships among them. | 201901229349101720 |
| 2018 | Regents of the University of Michigan Ann Arbor, MI | B | $150,000 | paid | To develop a novel cancer vaccine using artificial virus-like particles, and to analyze its efficacy in the development of anti-tumor clearance, and long-term immunity. | 201901229349101720 |
| 2018 | Loyola University of Chicago Maywood, IL | C | $150,000 | paid | To investigate how the transfer of alpha-synuclein between cells in the nervous system induces neuroinflammation that drives Parkinson's Disease pathogenesis. | 201901229349101720 |
| 2018 | Rockefeller University New York, NY | B | $150,000 | paid | To determine the role of BRCA2 and other DNA repair proteins, which are important for neural progenitor cells of the cerebellem, in the development of medulloblastoma, the most common pediatric brain malignancy. | 201901229349101720 |
| 2018 | Tisch Multiple Sclerosis Research Center of New York Inc New York, NY | B | $150,000 | paid | To elucidate the cause of MS by investigating 3 synergistic factors: 1) the initial trigger that generates the anitbody response in MS; 2) the role of Epstein - Barr virus in the development of autoimmunity in MS; and 3) the role of anti-myelin antibodies in sustaining the ongoing demyelination and disease. | 201901229349101720 |
| 2018 | Uc San Diego Foundation La Jolla, CA | U | $75,000 | paid | To examine how the downregulation of EdnrB, a gene found to be selective' in the high altitude human population, can preserve cardiovascular function during acute hyposia. | 201901229349101720 |
| 2018 | Hackensack University Medical Center Hackensack, NJ | U | $75,000 | paid | To evaluate potential therapies to decrease cell adhesion interaction-mediated drug resistance in multiple myeloma, a type of hematological cancer characterized by the uncontrollable proliferation of plasma immune cells in the bone marrow. | 201901229349101720 |
| 2018 | Uc San Diego Foundation La Jolla, CA | U | $75,000 | paid | To analyze sequencing data from subjects living in high altitude conditions in Kyrgystan with or without high altitude pulmonary hypertension, in order to select and screen candidate genes for the development of pulmonary hypertension. | 201901229349101720 |
| 2018 | Regents of the University of Michigan Ann Arbor, MI | B | $75,000 | paid | To study the role of a protein modification process known as AMPylation on heat shock protein function in the onset, development, and progression of neurodegenerative diseases (Alzheimer's, Parkinson's, and Huntington diseases) | 201901229349101720 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990-PF e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.